Starting
Initialising…
0%
NF1
Final classification
Likely Benign
NF1 c.369C>G · p.Thr123=
NF1

The NF1 c.369C>G (p.Thr123=) variant has been reported in ClinVar, where benign and likely benign classifications predominate.

Gene
NF1
Transcript
NM_000267.3
HGVS · transcript:coding
NM_000267.3:c.369C>G
Consequence
N/A
GRCh38
chr17:31163266 C>G
GRCh37
chr17:29490284 C>G
Basis Neurofibromatosis and Schwannomatosis Specification v1.0.0 lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: BS1 strong benign, BP7 supporting benign; combination = no applied criteria, which maps to Likely Benign.
Neurofibromatosis and Schwannomatosis Specification v1.0.0 lacked a usable explicit final combination framework, so generic ACMG/AMP 2015 final-combination rules were applied as fallback; applied criteria: BS1 strong benign, BP7 supporting benign; combination = no applied criteria, which maps to Likely Benign.
Classification rationale
BS1BP7 Likely Benign
NF1 c.369C>G

The NF1 c.369C>G (p.Thr123=) variant has been reported in ClinVar, where benign and likely benign classifications predominate.1 This variant is present in population databases at high frequency, including East Asian allele frequencies of 1.11791% in gnomAD v2.1 and 1.22098% in gnomAD v4.1, supporting BS1 and arguing against rarity-based pathogenic criteria.2 This synonymous variant is predicted to have no significant splice impact by SpliceAI, with a maximum delta score of 0.00, supporting BP7 and not supporting PP3.3

BS1 + BP7 Likely Benign
Gene diagram · NM_000267.3 · variants mapped to exon structure
NF1 NM_000267.3
Fetching transcript structure from UCSC…
Applied criteria · 2 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports benign
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 0.000368619; MAF= 0.03686%, 595/1614134 alleles, homozygotes = 8) and has highest observed frequency in the East Asian population (AF= 0.0122098; MAF= 1.22098%, 548/44882 alleles, homozygotes = 7); grpmax FAF= 0.0113641.
      v2.1
      This variant is present in gnomAD v2.1 (AF= 0.000820623; MAF= 0.08206%, 232/282712 alleles, homozygotes = 3) and has highest observed frequency in the East Asian population (AF= 0.0111791; MAF= 1.11791%, 223/19948 alleles, homozygotes = 3); grpmax FAF= 0.00989917.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      0.037% · 595 / 1,614,134
      8 hom · FAF 1.1%
      East Asian
      548 / 44,882
      1.2%
      7 hom
      Remaining individuals
      26 / 62,508
      0.042%
      1 hom
      South Asian
      18 / 91,082
      0.02%
      Admixed American
      1 / 60,012
      0.0017%
      European (non-Finnish)
      2 / 1,180,016
      0.00017%
      + 5 not observed (European (Finnish), Amish, Middle Eastern, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      0.082% · 232 / 282,712
      3 hom · FAF 0.99%
      East Asian
      223 / 19,948
      1.1%
      3 hom
      Remaining individuals
      5 / 7,212
      0.069%
      South Asian
      4 / 30,614
      0.013%
      + 5 not observed (African/African American, Admixed American, Ashkenazi Jewish, European (Finnish), European (non-Finnish))
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Benign (13 clinical laboratories) and as Likely benign (4 clinical laboratories). (ClinVarID = 184262)
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
      Functional / OncoKB screenshot
      Functional Unknown Oncogenic Effect
      OncoKB identified curated literature and non-variant-specific oncogenicity context for review; listed oncogenicity label: Unknown Oncogenic Effect.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV62214161, n = 1 times).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Sources & reference links
      8Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots